Comparing Mavyret vs Vosevi
Mavyret (glecaprevir / pibrentasvir) | Vosevi (sofosbuvir / velpatasvir / voxilaprevir) |
|
---|
Mavyret (glecaprevir / pibrentasvir) | Vosevi (sofosbuvir / velpatasvir / voxilaprevir) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Mavyret is an antiviral combination agent that is approved to treat all six genotypes (1-6) of acute or chronic hepatitis C virus (HCV) infection in adults and children aged 12 years of age and... View more |
Prescription only
Vosevi is a stand-alone combination antiviral treatment that may be used to treat HCV infection of genotypes 1 through 6 in adults who have been previously treated with certain other antiviral... View more |
Related suggestions Popular comparisons
|
|||||||||||||||
More about Mavyret (glecaprevir / pibrentasvir) | More about Vosevi (sofosbuvir / velpatasvir / voxilaprevir) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Mavyret has an average rating of 8.3 out of 10 from a total of 428 ratings on Drugs.com. 76% of reviewers reported a positive effect, while 7% reported a negative effect. |
Vosevi has an average rating of 10.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Mavyret side effects |
View all Vosevi side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Mavyret prices |
View all Vosevi prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
13 hours |
33 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 215 drugs are known to interact with Mavyret:
|
A total of 236 drugs are known to interact with Vosevi:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
August 03, 2017 |
N/A |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Epclusa
Epclusa treats chronic hepatitis C in adults and children 3+. This once-daily antiviral combines ...
Harvoni
Harvoni is used to treat hepatitis C virus (HCV) infections in adults and children aged 3 years and ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Sovaldi
Sovaldi (sofosbuvir) is used to treat chronic hepatitis C virus (HCV) infection. Includes Sovaldi ...
Vosevi
Vosevi (sofosbuvir,velpatasvir and voxilaprevir) is used to treat chronic hepatitis C. Includes ...
Pegasys
Pegasys is used to treat chronic hepatitis B or C. Learn about side effects, interactions and ...
Zepatier
Zepatier (elbasvir and grazoprevir) is used to treat chronic hepatitis C. Includes Zepatier side ...
Interferon alfa-2b
Interferon alfa-2b is used for angioblastoma, condylomata acuminata, conjunctival mucosa-associated ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.